CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.04
-0.08 (-3.77%)
At close: Aug 19, 2025, 11:44 AM
CytomX Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CTMX stock have an median target of 5, with a low estimate of 5 and a high estimate of 7. The median target predicts an increase of 145.10% from the current stock price of 2.04.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 5 | 5.67 | 5 | 7 |
| Change | 145.10% | 177.94% | 145.10% | 243.14% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Cyto... Unlock content with Pro Subscription
Updated May 20, 2025
| Rating | Nov 24 | Jan 25 | Mar 25 | Apr 25 | May 25 | Jul 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 3 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 3 | 1 |
Financial Forecast this Year
Revenue This Year
93.17M
from 138.1M
Increased by -32.5%
Revenue Next Year
49.84M
from 93.17M
Increased by -46.5%
EPS This Year
0.05
from 0.38
Increased by -86.8%
EPS Next Year
-0.31
from 0.05
Increased by -520%